Bank Of Montreal Regenxbio Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$19.35 - $35.04 $215,094 - $389,504	-11,116 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$24.62 - $34.31 $36,560 - $50,950	-1,485 Reduced 11.78%	11,116 $376,000
Q4 2021 Feb 11, 2022	SELL	$30.19 - $40.28 $325,568 - $434,379	-10,784 Reduced 46.12%	12,601 $416,000
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $28,653 - $44,994	-985 Reduced 4.04%	23,385 $1.02 Million
Q2 2021 Aug 12, 2021	BUY	$32.46 - $40.48 $791,050 - $986,497	24,370 New	24,370 $943,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $413M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.